City
Epaper

Researchers develop fast, accurate, low-cost Covid-19 test

By IANS | Updated: August 29, 2020 18:04 IST

Beijing, Aug 29 Chinese researchers have developed a new low-cost diagnostic test for Covid-19 which quickly delivers accurate ...

Open in App

Beijing, Aug 29 Chinese researchers have developed a new low-cost diagnostic test for Covid-19 which quickly delivers accurate results without the need for sophisticated equipment.

"In this study, we developed an isothermal, CRISPR-based diagnostic for Covid-19 with near single-copy sensitivity," the study authors from Xuzhou Medical University in China, wrote in a paper published in the journal PLOS Pathogens.

"We demonstrated a CRISPR-based assay for Covid-19 that offered shorter turn-around time and great diagnostic value, even in under-resourced settings without the need for thermal cyclers," they added.

The surging demand for rapid screening and identification of Covid-19 poses great diagnostic challenges.

Metagenomic next-generation sequencing (mNGS) and reverse-transcription PCR (RT-PCR) have been the most commonly used molecular methods for diagnosing Covid-19, but each has its own limitations.

For example, sequencing is costly and has a turnaround time of nearly one day, while RT-PCR requires specialized equipment and is difficult to deploy at a large scale.

According to the researchers, a lack of rapid and accurate molecular diagnostic tools has hampered efficient public health responses to the viral threat.

In the new study, the researchers developed an alternative Covid-19 test by leveraging CRISPR-based technology, which has been widely used in recent years for gene editing.

The assay, named CRISPR-COVID, enables high-throughput detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the virus that causes Covid-19.

CRISPR-COVID delivers comparable sensitivity and specificity as mNGS within as short as 40 minutes, the researchers said.

When produced at a large scale, the material cost of a CRISPR-COVID test could be less than 70 cents, suggesting that CRISPR-COVID is a competitive alternative not only technologically but also financially, the team noted.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Xuzhou Medical UniversityPlos pathogenschinabeijing
Open in App

Related Stories

InternationalTyphoon Ragasa Live Tracker Map: Deadly Cyclonic Storm Nears Vietnam After Wreaking Havoc in China, Hong Kong and Taiwan; Check Real-Time Status

CricketRashid Khan-Led Afghanistan Beat Hong Kong by 94 Runs in Asia Cup 2025 Opener (VIDEO)

InternationalPM Narendra Modi, Chinese President Xi Jinping and Russian President Vladimir Putin Seen Interacting at SCO Summit 2025 in China

OpinionsChina’s Move... Fictator’s Fortune!

InternationalChina SCO Summit 2025: Meet Xiao He, Humanoid Robot, Designed to Assist During Tianjin Summit (Watch)

Health Realted Stories

HealthSARS-CoV-2 reinfection can spike long Covid risk in kids: The Lancet

HealthFrom neglect to awareness: How Swachh Bharat Mission transformed national mindset on cleanliness

HealthHow to Get Rid of Headaches Naturally: Simple Home Remedies You Should Know

HealthYoung night shift workers more at risk of developing kidney stones: Study

HealthNavi Mumbai International Airport a monument shaped by thousands of hands, hearts: Gautam Adani